Patent Assignment
Reel/Frame 038684/0686
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 038506 Frame: 0881. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2016-05-11
Pages: 9
Assignor
PROTEOSYS AG
Executed: 2014-02-11
Assignee
MIND-NRG SA
2 RUE DE JARGONNANT, GENEVA, 1207, SWITZERLAND
Covered Properties
(4)
Method of Effecting Neuroprotection Using Soluble Neuregulin Isoforms
Application:
14/271,617 →
Publication:
US 2014/0243269
Pharmaceutical Composition Containing Neuregulin Isoforms
Application:
14/271,749 →
Publication:
US 2014/0243270
Method of Inhibiting Dopaminergic Cell Death
Application:
14/271,755 →
Publication:
US 2014/0323408
Active Soluble Post-Translationally Modified Neuregulin Isoforms
Application:
14/563,427 →
Publication:
US 2015/0239948
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 11, 2016
From: SCHRATTENHOLZ, ANDRE
To: PROTEOSYS AG
Reel/Frame 038241/0359 →
Assignment of Assignor's Interest
Apr 25, 2016
From: PROTEOSYS AG
To: MING-NRG SA
Reel/Frame 038506/0881 →
Change of Name
Jul 8, 2016
From: MIND-NRG SA
To: MIND-NRG SARL
Reel/Frame 039289/0137 →